Read the Bissonette’s Story

Seed Grant Program

Muscular Dystrophy Canada increases funding for Seed Grant Program

Research-CC1_200

Toronto, Canada – Muscular Dystrophy Canada (MDC) has increased the funding envelope for their Seed Grant Program to $250,000 to support research projects that receive excellent evaluations through the peer review process. It is estimated that 5-6 proposals will be awarded funding.

The intent of the Seed Grant program is to solicit research proposals related to neuromuscular diseases, specifically proposals that are not entirely focused on a single disorder, but are relevant to several of the 150 plus disorders covered by Muscular Dystrophy Canada.

“Launched in 2012, the Seed Grant Program continues to demonstrate meaningful impact. Originally focused on Respiratory Care, this year’s program will be broader in scope.” commented, Barbara Stead-Coyle, CEO of Muscular Dystrophy Canada.  “Recent consultations with our key stakeholders reiterated the need for an increased investment in research and we are happy to announce this as the first step.”

From April 2016 – January 2017, MDC staff conducted a needs assessment and analysis process as an outcome from an Ontario based pilot. The goal of this analysis was to better understand the needs of the neuromuscular community. Participants included individuals with a neuromuscular disorder, family members, caregivers, Health Care Providers, Service Organizations and key volunteers.

Many key stakeholders expressed the need for increased research activities focusing on:

  • Treatments and cures
  • Decreasing secondary health conditions
  • Understanding of the impact of community care policies on quality of life and the promotion of integrated living
  • Improving quality of life through use of assistive technology
  • Understanding the financial cost of living with a neuromuscular disorder
  • Determining the benefits of exercise
  • Understanding psychosocial behavior

“This round of Seed Grants has been designed to align with these findings.” added Debra Chiabai, Interim Chair of the Medical and Scientific Advisory Committee. “The Committee is excited to see what new and innovative projects will come to us as part of this call.”

Past Seed Grants were focused on improving the respiratory health outcomes of people living with neuromuscular disorders. These projects provided solid evidence and enhanced our understanding of how to prevent and treat respiratory complication.

The deadline for submissions is June 30, 2017.

To apply,  click on the link to download details on the RFP and Application – 2017 Seed Grant Program

 

Applications will be awarded through a competitive peer-review process. Proposals will be reviewed by Muscular Dystrophy’s Medical and Scientific Advisory Committee.

 

About Muscular Dystrophy Canada

Muscular Dystrophy Canada’s mission is to enhance the lives of those affected with neuromuscular disorders by continually working to provide ongoing support and resources while relentlessly searching for a cure through well funded research. To learn more about Muscular Dystrophy Canada – please visit www.muscle.ca or call our toll-free number at 1-866-MUSCLE-8 (1-866-687-2538).

 

Media contact information:
Jesse Sharratt
Director of Marketing and Communications
Muscular Dystrophy Canada
jesse.sharratt@muscle.ca
416-488-0030 ext 1120
WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann